Hypaque Injection and Lanreotide Subcutaneous
Determining the interaction of Hypaque Injection and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Diatrizoate Meglumine
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque Injection-Lansoprazole
- Hypaque Injection-Lansoprazole Delayed-Release Capsules
- Hypaque Injection-Lansoprazole Orally Disintegrating Tablets
- Hypaque Injection-Lansoprazole, Amoxicillin, and Clarithromycin
- Hypaque Injection-Lanthanum
- Hypaque Injection-Lanthanum carbonate
- Lanreotide Subcutaneous-Hypaque Meglumine
- Lanreotide Subcutaneous-Hypaque-76
- Lanreotide Subcutaneous-Hypaque-Cysto
- Lanreotide Subcutaneous-Hyper-Sal inhalation
- Lanreotide Subcutaneous-Hyperhep B
- Lanreotide Subcutaneous-HyperHEP B S/D